758 results on '"Jett, James R."'
Search Results
2. Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies
3. Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review
4. The Intersection of Lung Cancer Screening, Radiomics, and Artificial Intelligence: Can One Scan Really Predict the Future Development of Lung Cancer?
5. Supplementary Figures 1-3, Tables 1-4 from Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules
6. Scientific Advances in Thoracic Oncology 2016
7. Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non–Small Cell Lung Cancer: NCCTG N0028 (Alliance)
8. Clinical Presentation and Diagnosis of Tracheal Neoplasms
9. Contributors
10. Screening for Lung Cancer
11. Malignant Pleural Mesothelioma
12. Development of a multivariate model to predict the likelihood of carcinoma in patients with indeterminate peripheral lung nodules after a nondiagnostic bronchoscopic evaluation
13. Contributors
14. Clinical Aspects of Lung Cancer
15. Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer
16. Non-small-cell lung cancer
17. Screening for Lung Cancer. Improving Outcomes with Better Patient Selection
18. Are Airflow Obstruction and Radiographic Evidence of Emphysema Risk Factors for Lung Cancer?: A Nested Case-Control Study Using Quantitative Emphysema Analysis
19. 5-Year Lung Cancer Screening Experience: Growth Curves of 18 Lung Cancers Compared to Histologic Type, CT Attenuation, Stage, Survival, and Size
20. An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management
21. Evaluation of Glutathione Metabolic Genes on Outcomes in Advanced Non-small Cell Lung Cancer Patients after Initial Treatment with Platinum-Based Chemotherapy: An NCCTG-97-24-51 Based Study
22. Utility of Integrated Computed Tomography—Positron Emission Tomography for Selection of Operable Malignant Pleural Mesothelioma
23. Treatment of Small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
24. Assessment of Integrated Classifier’s Ability to Distinguish Benign From Malignant Lung Nodules
25. Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)
26. Targeted Therapy for Non-Small Cell Lung Cancer
27. Screening for lung cancer: The US studies
28. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of position emission tomography in diagnosis
29. Computed tomography screening and lung cancer outcomes
30. A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients
31. Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients
32. Acknowledgments
33. Mitwirkende Autoren
34. Systemic Treatment of Advanced Lung Carcinoid Tumors: Show Me the Data!
35. Changing of the Guard
36. Malignant Pleural Mesothelioma
37. CONTRIBUTORS
38. A Comparison of Cytology and Fluorescence in Situ Hybridization for the Detection of Lung Cancer in Bronchoscopic Specimens
39. Impact of Pretreatment Factors on Adverse Events: A Pooled Analysis of North Central Cancer Treatment Group Advanced Stage Non-small Cell Lung Cancer Trials
40. Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer
41. Contributors
42. Clinical Aspects of Lung Cancer
43. Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America
44. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups
45. Brief Report: A Phase II “Window-of-Opportunity” Frontline Study of the mTOR Inhibitor, Temsirolimus Given as a Single Agent in Patients with Advanced NSCLC, an NCCTG Study
46. Encouragement to Submit Data of Clinical Response to EGFR-TKIs in Patients With Uncommon EGFR Mutations
47. Status of Journal of Thoracic Oncology in 2011
48. Lung Tumors
49. Malignant Pleural Mesothelioma
50. Contributors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.